12-Month prevalence of allergies in Germany by Schmitz, Roma et al.
FACT SHEET
Journal of Health Monitoring 2017 2(1)
Journal of Health Monitoring 12-Month prevalence of allergies in Germany
12-Month prevalence of allergies in Germany
Abstract
The prevalence of allergies has increased dramatically during recent decades, and thus, got into the focus of public 
health. As part of the 2014 German Health Update (GEDA 2014/2015-EHIS), 28.1% of respondents reported that 
they were affected by an allergic disease other than asthma. Reports of allergies are more common among women 
than men and among younger and middle-aged adults than people over the age of 65. Adults with higher levels of 
education stated more frequently that they are affected by allergies than adults with lower levels of education. Allergic 
reactions occur in various organ systems, but the skin, mucous membranes, respiratory tract and the intestines 
are most commonly affected. As allergic reactions often significantly restrict people’s quality of life, early diagnosis 
and appropriate care for sufferers is essential.
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Introduction
Well-known symptoms of allergies include a runny nose, 
sneezing, itchy eyes, breathing difficulties up to short-
ness of breath, and severe itching of the skin. Allergic 
reactions are triggered by an excessive reaction of the 
body’s immune system to otherwise harmless environ-
mental substances (allergens). Allergens are widespread 
and people are exposed to them through inhalation, diet 
and direct contact; they normally consist of proteins or 
protein compounds but have a variety of chemical and 
physical characteristics. Allergic reactions occur in a 
range of the body’s organ systems, with the skin and 
mucous membranes (hay fever, atopic dermatitis and 
allergic contact dermatitis), the respiratory tract (asth-
ma), the oral cavity and the intestinal tract (food aller-
gies) the most commonly affected. Type I reactions 
(immediate hypersensitivity) such as hay fever and 
atopic dermatitis involve the production of allergen-spe-
cific immunoglobulin E antibodies (IgE). Allergic sensi-
tisation (atopy) is said to have occurred if these antibod-
ies are detectable in the blood. In other allergic disorders, 
such as allergic contact dermatitis, an allergic reaction 
is delayed (Type IV hypersensitivity), and is mediated by 
specific white blood cells (T-cells) [1]. 
Since the 1970s, allergies have become significantly 
more common in Germany [2-7]. Estimates suggest that 
up to 30 million people are currently affected, and their 
quality of life and capabilities can be greatly restricted 
[8]. Moreover, chronic allergic disorders are usually asso-
ciated with a high degree of care needs. In cases where 
it is impossible or very difficult to avoid exposure to spe-
cific allergens, allergy sufferers – depending on the extent 
of their disorder – remain reliant on medical treatment 
for their individual complaints, or specific immunother-
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apy as the only existing form of causal therapy so far. No 
detailed calculations of the costs of allergic conditions 
in total are available for Germany.
Indicator
In the 2014 German Health Update (GEDA 2014/2015-
EHIS) the prevalence of allergic disease in the 12-month 
period that preceded the study was defined by a positive 
answer to the question ‘Have you had allergy, such as rhi-
nitis, hay fever, eye inflammation, dermatitis, food allergy 
or other (allergic asthma excluded) in the past 12 month?’ 
This indicator describes 12-month prevalence of self-as-
sessed current affection by an allergic disease other than 
asthma.
Analysis is based on data from 23,342 participants 
aged 18 and above with available information about their 
12-month allergy prevalence (674 participants were
excluded from the analysis because of missing informa-
tion). A weighting factor was applied throughout statis-
tical analysis that corrected the sample for deviations
from the German population (as of 31 December 2014)
in terms of gender, age, type of municipality and level of
education. The article entitled German Health Update –
New data for Germany and Europe [9], published in this
issue, provides a detailed description of the study meth-
odology. A detailed description of health monitoring and
health indicators in Europe is provided by a Focus arti-
cle [10] that is also published in this issue.
Results and discussion
28.1% of the adults reported that they are currently affect-
ed by allergies other than allergic asthma. Women – at 
31.6% – are significantly more likely to report that they 
are affected by allergies than men – at 24.5%. Young and 
middle-aged adults (up to 65 years of age) more fre-
quently report that they are affected by allergies than 
older people. Adults with higher levels of education are 
particularly affected by allergies. This is especially the 
case with middle-aged adults aged between the ages of 
30 and 64. The tables present the 12-month prevalence 
of allergies among 18- to 79-year-old adults stratified by 
gender, age and educational background (ISCED classi-
fication of low, medium and high education [11]).
Allergies are on the one hand caused by genetic fac-
tors. On the other hand, various non-genetic factors are 
discussed to be responsible for the significant rise in 
allergic disease prevalence that has occurred in recent 
decades. These factors have long been subject to inten-
sive research and include reduced exposure to microor-
ganisms and infectious agents, reductions in parasitic 
diseases, increased exposure to allergens, environmen-
tal pollution and changes to the intestinal flora, but also 
changes to diet, lifestyle and travelling patterns [12-14]. 
The results of the German Health Update show that 
about one third of adults aged between 18 and 79 years 
assess themselves as suffering from an allergic condi-
tion. The higher prevalence of allergies among women 
than men and in individuals with the highest levels of 
education is well-known [15].
Although there was no assessment of single allergic 
conditions, the results still demonstrate a considerable 
potential for disease. It can be assumed that each pos-
itive response to the study’s question on allergies was 
also linked to a certain level of psychological strain and 
GEDA 2014/2015-EHIS
Data holder: Robert Koch Institute
Aims:  to provide reliable informa-
tion about the population’s 
health status, health-related 
behaviour and health care in 
Germany, with the possibility 
of a European comparison
Method:   questionnaires completed 
on paper or online
Population:   people aged 18 years and 
above with permanent resi-
dency in Germany
Sampling:   registry office sample; ran-
domly selected individuals 
from 301 communities in 
Germany were invited to par-
ticipate
Participants:   24,016 people (10,872 men; 
13,144 women)
Response rate:  26.9%
Study period:  November 2014 – July 2015
Data protection:  all participants were informed 
about the study’s aims and 
content and about data pro-
tection, and provided their 
informed consent
More information is available at 
www.geda-studie.de
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Women % (95%-CI)
Women total 31.6 (30.5-32.7)
18 – 29 Years 38.7 (36.4-41.0)
Low education 36.2 (30.6-42.2)
Medium education 39.8 (36.8-42.9)
High education 37.9 (33.2-42.9)
30 – 44 Years 34.8 (32.5-37.1)
Low education 25.5 (19.6-32.4)
Medium education 35.3 (32.3-38.5)
High education 38.5 (35.0-42.2)
45 – 64 Years 32.4 (30.7-34.2)
Low education 32.6 (28.4-37.0)
Medium education 31.2 (29.0-33.5)
High education 36.4 (33.6-39.4)
≥ 65 Years 23.3 (21.2-25.5)
Low education 21.5 (18.4-24.9)
Medium education 24.8 (21.8-28.1)
High education 24.1 (20.1-28.7)
Total (women and men) 28.1 (27.3-29.0)
CI=Confidence interval
Men % (95%-CI)
Men total 24.5 (23.4-25.7)
18 – 29 Years 31.4 (28.8-34.1)
Low education 29.4 (23.5-36.0)
Medium education 32.3 (28.7-36.1)
High education 32.0 (26.4-38.1)
30 – 44 Years 28.2 (25.9-30.6)
Low education 24.8 (18.2-32.8)
Medium education 26.4 (23.5-29.5)
High education 33.2 (29.9-36.7)
45 – 64 Years 23.6 (22.1-25.3)
Low education 21.6 (17.5-26.4)
Medium education 22.1 (19.9-24.5)
High education 27.3 (24.9-29.9)
≥ 65 Years 16.2 (14.6-18.0)
Low education 15.0 (11.5-19.2)
Medium education 15.9 (13.5-18.6)
High education 17.5 (15.0-20.2)
Total (women and men) 28.1 (27.3-29.0)
(at the very least, symptomatic) medical treatment. How-
ever, it has to be noted that laypeople (due to their lack 
of medical training) often have difficulties in differenti-
ating allergies from ‘pseudo-allergies’ (particularly food 
intolerances), since both can produce similar symptoms. 
This is one of the reasons why large-scale national and 
international epidemiological studies ask questions 
about specific allergic diseases and often include ques-
tions about whether these diseases have been diagnosed 
by a doctor. Such questions were included in the Euro-
pean ECHRS study (European Community Respiratory 
Health Survey) and DEGS1 (German Health Interview 
and Examination Survey for Adults), a representative 
study of the German adult population, for example.
From data of DEGS1, which was conducted between 
2008 and 2011 using computer-assisted medical inter-
views, a 12-month prevalence of nearly 20% for the pres-
ence of at least one of seven queried (medically diag-
nosed) allergies including asthma was estimated [5]. 
However, estimates of prevalence based on reported 
medical diagnoses tend to be lower than those ascer-
tained through self-assessments, as many sufferers who 
have mild symptoms do not visit a doctor.
With respect to time trend in the 12-month prevalence 
based on self-assessments among adults in Germany, 
data from three surveys are available for allergic rhinitis 
Approximately one third of 
women but only one quarter 
of men are currently affected 
by allergies other than  
allergic asthma.
Table 1 
The 12-month prevalence of allergies among 
18- to 79-year-old adults, according to
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(hay fever) [4, 16]. These data demonstrate that the 
12-month prevalence almost doubled between 1990/1992
and 2008/2011. Approximately 12.3 million adults in Ger-
many declare to suffer from allergic rhinitis.
Due to the large number of people they affect, allergic 
diseases are highly relevant to public health. In addition 
to continuous allergy monitoring and further research on 
potential risk and protective factors, more efforts are 
needed to ensure early diagnoses and to develop appro-
priate forms of care for allergy sufferers. This is not only 
important for the quality of life of those affected; it is also 
essential from an economic perspective [8].
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Allergic disease is more  
often reported from adults 
with the highest levels of 
education compared to those 
with lower levels.
The 12-month prevalence  
of allergic disease is higher 
among adults under 65 than 
among those over 65 years  
of age.
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